PETALING JAYA: The world’s first dengue vaccine Dengvaxia may have negative long-term effects on those who have never had dengue infection, says Health Ministry director-general Datuk Dr Noor Hisham Abdullah. Dr Noor Hisham stressed that the Drug Control Authority is careful in the approval process of any pharmaceutical product registration. The Philippines is among the countries, including Mexico, El Salvador, Brazil, Singapore and Costa Rica, where Dengvaxia has been approved for marketing. He also urged the public to check if a pharmaceutical product is registered by checking its hologram seal and that it is labelled with a legitimate product registration number. The registration status of the pharmaceutical product could also be checked on http://npra.moh.gov.my.

Source: The Star December 02, 2017 23:03 UTC